Mahasweta Gooptu

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Mahasweta Gooptu

Jan 29, 2025, 12:07 | Blog

Celebrating Life: A Stem Cell Recipient Meets Her Donor at the NMDP ONE Forum - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn: "Each year at the NMDP’s (formerly known…

Jan 10, 2025, 23:34 | Science

H. Moses Murdock: How I Treat AML relapse after allogeneic HCT

H. Moses Murdock, Hematology/Oncology fellow at Dana-Farber Cancer Institute, shared a post on X about…

Jan 9, 2025, 17:04 | Blog

Mehdi Hamadani: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide

Mehdi Hamadani shared on X: "Our new BMT CTN 1703 analysis busts a few myths:…

Jul 20, 2024, 12:53 | Insight

Cyclophosphamide–Based GVHD Prophylaxis Reduces Outcome Disparity in Transplants

CIBMTR shared a post on X about a recent paper. . Authors: Brian C. Shaffer,…

May 31, 2024, 13:48 | Blog

Dana-Farber researchers and faculty made an impressive showing at this year's ASTCT Meeting

Dana-Farber Cancer Institute shared on their LinkedIn: . "Dana-Farber researchers and faculty made an impressive showing…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023